Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Abelcet
Active Ingredient: Amphotericin B 5mg/mL
Dosage Form: Emulsion for infusion
New Zealand Sponsor: Amgen New Zealand Branch Amgen Australia Pty Limited
Manufacturer: The Liposome Company Inc, Indianapolis, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 29th day of February 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).